Outsourced Pharma Capacity Update (April 2025): Cell & Gene Therapy

Discover how FUJIFILM Diosynth Biotechnologies’ global end-to-end cell and gene therapy capabilities support the full product lifecycle – whatever your challenge, you’ll find a solution within our network.

Serat Ali, Director, Commercial Development at FUJIFILM Diosynth Biotechnologies, will present an update on the current and future state of our cell and gene capabilities.

Register here.